Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial

Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial

<p>Abstract</p> <p>Background</p> <p>Although highly active antiretroviral therapy (HAART) has dramatically decreased HIV-related morbidity and mortality, the associated costs, toxicities, and resistance risks make the potential delay of HAART initiation an attractive g...

Full description

Bibliographic Details
Main Authors: Cahn Pedro, Grinsztejn Beatriz, Kaul Rupert, Raboud Janet M, Tan Darrell HS, Walmsley Sharon L
Format: Article
Language:English
Published: BMC 2010-11-01
Series:Trials
Online Access:http://www.trialsjournal.com/content/11/1/113

Similar Items

Similar Items